This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Michigan. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Andrew W. Robertson
Introduction
Andrew W. Robertson is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical research, particularly in the treatment of HIV. His work focuses on developing compounds that can inhibit MHC-I downmodulation, which is crucial for treating HIV infection.
Latest Patents
Robertson holds a patent titled "Inhibitors of MHC-I Nef downmodulation for treating HIV." This patent outlines compounds that can effectively inhibit MHC-I downmodulation, providing a potential treatment option for patients suffering from HIV infection. He has 1 patent to his name, showcasing his innovative approach to addressing this critical health issue.
Career Highlights
Andrew W. Robertson is affiliated with the University of Michigan, where he conducts his research and development work. His position at such a prestigious institution highlights his expertise and commitment to advancing medical science.
Collaborations
Robertson has collaborated with esteemed colleagues, including Mark M. Painter and David H. Sherman. These partnerships reflect the collaborative nature of research in the medical field, where diverse expertise can lead to groundbreaking innovations.
Conclusion
Andrew W. Robertson's contributions to HIV treatment through his innovative patent demonstrate the importance of research and development in addressing global health challenges. His work at the University of Michigan and collaborations with other experts further enhance the impact of his inventions.